Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Feb 14, 2012	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	1,801	$111.01	392,585
Feb 14, 2012	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	234,616	$13.00	390,679
Dec 11, 2023	SCHLEIFER LEONARD S Director, Bd. Co-Chair, President & CEO	Director, Bd. Co-Chair, President & CEO	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	25,155	--	387,270
Feb 15, 2012	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	6,257	$111.01	386,328
Dec 12, 2019	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	64,754	$377.16	384,208
May 01, 2012	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Open market or private sale of non-derivative or derivative security	2,300	$133.86	384,028
Feb 14, 2012	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	95,016	$111.01	379,002
Dec 11, 2023	SCHLEIFER LEONARD S Director, Bd. Co-Chair, President & CEO	Director, Bd. Co-Chair, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	12,841	$844.09	374,429
Feb 14, 2012	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	27,475	$111.01	363,204
Dec 13, 2018	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	96,079	$377.31	363,014

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media